Abstract: The present disclosure proposes a lamp with a replaceable power supply module, the lamp including: a lamp body; a power supply module electrically connected to the lamp body to supply power to the lamp body, the power supply module being disposed on the lamp body and provided with a locking portion; and a catch, the catch being provided with a catch body and an elastic member connected to the lamp body, the catch body being rotatably connected to the elastic member, and the locking portion being provided with a locking protrusion, wherein the catch body has a catch recess and a mounting opening, the catch recess mating with the locking protrusion, and the mounting opening being located below the catch recess and configured to allow the locking protrusion to enter and exit the catch recess.

Abstract: The present application provides a lamp with a removable lens, the lamp comprising: a lamp body provided with a mounting portion, a mounting groove being provided in the middle of the mounting portion; a lamp panel arranged on the mounting portion; a lens arranged on a top surface of the lamp panel, a connector being provided in the middle of the lens; a pressing frame, the pressing frame being pivotally arranged on the lamp body such that the pressing frame is capable of being flipped relative to the lamp body, the pressing frame being arranged around the mounting portion, and the pressing frame being in close fit with an upper edge of the lens so as to tightly press the lens on the lamp body; a snap-fit structure arranged between the lamp body and the pressing frame, the snap-fit structure fixing the lamp body and the pressing frame when the pressing frame closely fits with the upper edge of the lens; and a press-type latch structure arranged in the mounting groove, the press-type latch structure having a l

Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.

Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.

Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.

Abstract: The present invention provides biomarkers and diagnostic methods employing such biomarkers based on the discovery of genes that have a two-fold or greater difference in gene expression in the spinal cord of a pre-symptomatic mouse model of amyotrophic lateral sclerosis. Such biomarkers and diagnostic methods are useful for early detection of neural cell injury and death in acute and degenerative disease.

Abstract: The invention provides isolated N-methyl-D-aspartate type 3B (NR3B) polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.

Abstract: The invention provides isolated NR3B polypeptides, functional fragments and peptides, encoding nucleic acid molecules and polynucleotides, and specific antibodies. Also provided are excitatory glycine receptors, containing either NR3B or NR3A polypeptides. Further provided are methods for detecting excitatory glycine receptor ligands, agonists and antagonists. The invention also provides related diagnostic and therapeutic methods.